Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34186102781;102782;102783 chr2:178534059;178534058;178534057chr2:179398786;179398785;179398784
N2AB3254597858;97859;97860 chr2:178534059;178534058;178534057chr2:179398786;179398785;179398784
N2A3161895077;95078;95079 chr2:178534059;178534058;178534057chr2:179398786;179398785;179398784
N2B2512175586;75587;75588 chr2:178534059;178534058;178534057chr2:179398786;179398785;179398784
Novex-12524675961;75962;75963 chr2:178534059;178534058;178534057chr2:179398786;179398785;179398784
Novex-22531376162;76163;76164 chr2:178534059;178534058;178534057chr2:179398786;179398785;179398784
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Ig-160
  • Domain position: 50
  • Structural Position: 125
  • Q(SASA): 0.3045
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I rs768158620 0.24 0.998 N 0.723 0.354 0.541648499649 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.86E-06 0
T/I rs768158620 0.24 0.998 N 0.723 0.354 0.541648499649 gnomAD-4.0.0 1.59098E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85767E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1045 likely_benign 0.1104 benign -0.577 Destabilizing 0.948 D 0.419 neutral N 0.461332732 None None N
T/C 0.4888 ambiguous 0.5579 ambiguous -0.387 Destabilizing 1.0 D 0.671 neutral None None None None N
T/D 0.4002 ambiguous 0.4211 ambiguous -0.024 Destabilizing 0.998 D 0.641 neutral None None None None N
T/E 0.3045 likely_benign 0.3142 benign -0.016 Destabilizing 0.998 D 0.65 neutral None None None None N
T/F 0.318 likely_benign 0.3189 benign -0.567 Destabilizing 1.0 D 0.725 prob.delet. None None None None N
T/G 0.3357 likely_benign 0.3532 ambiguous -0.844 Destabilizing 0.992 D 0.565 neutral None None None None N
T/H 0.2312 likely_benign 0.2354 benign -1.096 Destabilizing 1.0 D 0.686 prob.neutral None None None None N
T/I 0.1784 likely_benign 0.1812 benign 0.04 Stabilizing 0.998 D 0.723 prob.delet. N 0.450233091 None None N
T/K 0.1607 likely_benign 0.162 benign -0.67 Destabilizing 0.998 D 0.647 neutral None None None None N
T/L 0.1445 likely_benign 0.1468 benign 0.04 Stabilizing 0.996 D 0.577 neutral None None None None N
T/M 0.1288 likely_benign 0.1405 benign 0.101 Stabilizing 1.0 D 0.672 neutral None None None None N
T/N 0.1361 likely_benign 0.1478 benign -0.588 Destabilizing 0.997 D 0.583 neutral N 0.462199523 None None N
T/P 0.6939 likely_pathogenic 0.7127 pathogenic -0.132 Destabilizing 0.998 D 0.729 prob.delet. D 0.524672134 None None N
T/Q 0.2095 likely_benign 0.2195 benign -0.677 Destabilizing 0.999 D 0.722 prob.delet. None None None None N
T/R 0.1399 likely_benign 0.1421 benign -0.491 Destabilizing 0.999 D 0.732 prob.delet. None None None None N
T/S 0.119 likely_benign 0.1244 benign -0.838 Destabilizing 0.775 D 0.215 neutral N 0.411789346 None None N
T/V 0.1712 likely_benign 0.1764 benign -0.132 Destabilizing 0.996 D 0.519 neutral None None None None N
T/W 0.7094 likely_pathogenic 0.7288 pathogenic -0.567 Destabilizing 1.0 D 0.691 prob.neutral None None None None N
T/Y 0.3585 ambiguous 0.3807 ambiguous -0.322 Destabilizing 1.0 D 0.716 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.